Jennison Associates LLC Penumbra Inc Transaction History

Jennison Associates LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$172.27 - $223.95 $2.53 Million - $3.29 Million	-14,675 Reduced 16.84%	72,464 $13 Million
Q1 2024 May 02, 2024	BUY	$220.09 - $273.15 $12.6 Million - $15.7 Million	57,310 Added 192.13%	87,139 $19.4 Million
Q4 2023 Feb 01, 2024	BUY	$181.44 - $260.22 $5.41 Million - $7.76 Million	29,829 New	29,829 $7.5 Million
Q2 2018 Aug 02, 2018	SELL	$112.2 - $165.95 $320,218 - $473,621	-2,854 Closed	0 $0
Q1 2018 Apr 20, 2018	SELL	$84.6 - $126.1 $104,396 - $155,607	-1,234 Reduced 30.19%	2,854 $330,000
Q4 2017 Jan 25, 2018	BUY	$91.55 - $115.85 $2,746 - $3,475	30 Added 0.74%	4,088 $385,000
Q3 2017 Nov 03, 2017	BUY	$79.65 - $90.3 $323,219 - $366,437	4,058	4,058 $366,000

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.11B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.